TRANSMEDICS COMPANY OVERVIEW

TransMedics, Inc., headquartered in Andover, MA, is the world’s leader in portable ex-vivo warm perfusion and assessment of donor organs for transplantation.  The company has developed the Organ Care System (OCS™) platform, a revolutionary first-in-class technology to improve organ quality, validate organ viability, and increase the utilization of transplant organs for the treatment of end-stage heart, lung, liver and kidney failure. This multi-organ platform has the potential to improve outcomes for transplant patients and to dramatically increase the number of transplantable organs worldwide.

The OCS™ Heart and OCS™ Lung systems are CE-marked and in clinical use in leading transplant centers in Europe, Australia and Canada, and undergoing FDA-approval clinical trials in the United States.   The new OCS™ Liver system is in clinical trials in the US and Europe, and the OCS™ Kidney technology is in development.

LEARN MORE

• The Organ Care System 
• OCS™ Heart
• OCS™ Lung
• OCS™ Liver